Karolinska Development AB (publ) (STO: KDEV)
Sweden
· Delayed Price · Currency is SEK
1.212
+0.010 (0.83%)
Oct 4, 2024, 4:48 PM CET
Karolinska Development AB Revenue
Karolinska Development AB had revenue of 487.00K SEK in the quarter ending June 30, 2024, a decrease of -6.53%. This brings the company's revenue in the last twelve months to 1.90M, down -11.82% year-over-year. In the year 2023, Karolinska Development AB had annual revenue of 2.01M, down -12.43%.
Revenue (ttm)
1.90M
Revenue Growth
-11.82%
P/S Ratio
171.87
Revenue / Employee
237.88K
Employees
8
Market Cap
327.04M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.01M | -286.00K | -12.43% |
Dec 31, 2022 | 2.30M | 130.00K | 5.99% |
Dec 31, 2021 | 2.17M | -481.00K | -18.14% |
Dec 31, 2020 | 2.65M | -733.00K | -21.66% |
Dec 31, 2019 | 3.38M | 311.00K | 10.12% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 520.76B |
Swedish Orphan Biovitrum AB (publ) | 23.71B |
Getinge AB (publ) | 33.33B |
Sectra AB (publ) | 3.17B |
Camurus AB (publ) | 1.59B |
Vitrolife AB (publ) | 3.54B |
Medicover AB (publ) | 21.70B |
Elekta AB (publ) | 18.12B |